Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2019  |  Volume : 29  |  Issue : 1  |  Page : 1-6

Left atrial volume during stress is associated with increased risk of arrhythmias in patients with hypertrophic cardiomyopathy


1 Cardiomyopathies and Heart Failure Department, Monaldi Hospital; Department of Traslational Sciences, Università della Campania “Luigi Vanvitelli," Nocera Inferiore, Italy; Inherited Cardiovascular Disease Unit, Institute of Cardiovascular Sciences, University College of London, London, UK
2 Cardiomyopathies and Heart Failure Department, Monaldi Hospital; Department of Traslational Sciences, Università della Campania “Luigi Vanvitelli," Nocera Inferiore, Italy
3 Cardiology Unit, Umberto I Hospital, Nocera Inferiore, Italy
4 Cardiology Department, Ospedale Fatebenefratelli, Benevento, Italy
5 CNR Institute of Clinical Physiology, Pisa, Italy
6 Inherited Cardiovascular Disease Unit, Institute of Cardiovascular Sciences, University College of London, London, UK

Correspondence Address:
Giuseppe Limongelli
Monaldi Hospital, AORN Colli, Via L Bianchi 1, 80131, Naples

Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jcecho.jcecho_45_18

Rights and Permissions

Introduction: In patients affected by hypertrophic cardiomyopathy (HCM), left atrial volume index (LAVi) is associated with an increased risk of tachyarrhythmias and major clinical events. To date, the clinical meaning of LAVi measured during exercise (stress LAVi [sLAVi]) has not yet been investigated in HCM. This study sought to evaluate the correlation between LAVi/sLAVi and clinical outcome (risk of arrhythmias and heart failure [HF]) in patients with HCM. Methods and Results: We enrolled a total of 51 consecutive patients with HCM (39 men; mean age: 39.41 ± 17.9 years) who underwent standard and stress echocardiography, following a common protocol. During follow-up (median follow-up was 1.82 years), the following composite endpoints were collected: ARRHYT endpoint (atrial fibrillation, paroxysmal supraventricular tachycardia, nonsustained ventricular tachycardia (VT), sustained VT, ventricular fibrillation, syncope of likely cardiogenic nature, and sudden cardiac death) and HF endpoint (worsening of functional class and left ventricular ejection fraction, hospitalization, and death for end-stage HF). Eight patients were lost at follow-up. ARRHYT endpoint occurred in 13 (30.2%) patients (8, 18.6%, supraventricular and 10, 23.2%, ventricular arrhythmias), whereas HF endpoint occurred in 5 (11.6%) patients. sLAVi (mean value of 31.16 ± 10.15 mL/m2) performed better than rLAVi as a predictor of ARRHYT endpoint (Akaike Information Criterion: 48.37 vs. 50.37, if dichotomized according to the median values). A sLAVi value of 30 mL/m2 showed a predictive accuracy of 72.1% (C-statistics of 0.7346), with a high negative predictive value (87.5%). Conclusion: These findings encourage future studies on sLAVi, as a potential predictor of arrhythmias and adverse outcome in patients with HCM.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1136    
    Printed78    
    Emailed0    
    PDF Downloaded91    
    Comments [Add]    

Recommend this journal